Arcellx Completes Acquisition by Gilead Sciences, Initiates Nasdaq Delisting

summarizeSummary

Arcellx, Inc. announced the completion of its acquisition by Gilead Sciences, Inc. for $115.00 per share in cash plus a contingent value right, leading to its delisting from Nasdaq and a change in corporate control.

check_boxKey Events

• Acquisition Completed

  Gilead Sciences, Inc. successfully acquired Arcellx, Inc. for $115.00 per share in cash plus one contingent value right (CVR) for $5.00, totaling approximately $7.1 billion. The tender offer expired on April 27, 2026, with 77.2% of shares tendered, and the merger was completed on April 28, 2026.

• Delisting from Nasdaq

  Arcellx's common stock will be delisted from Nasdaq, and the company intends to terminate its registration under the Exchange Act, suspending its public reporting obligations.

• Change in Control and Leadership

  Arcellx is now a wholly-owned subsidiary of Gilead Sciences. All previous directors and officers resigned, and new directors and officers from Gilead Sciences were appointed.

• Charter Amendments

  The company's certificate of incorporation and bylaws were amended and restated in their entirety to reflect its new status as a private subsidiary.

auto_awesomeAnalysis

This 8-K filing formally confirms the completion of the acquisition of Arcellx by Gilead Sciences, Inc., a previously announced and highly anticipated event. The transaction, valued at approximately $7.1 billion, results in Arcellx becoming a wholly-owned subsidiary of Gilead. Key implications include the immediate delisting of Arcellx's common stock from Nasdaq, the termination of its public reporting obligations, and a complete change in its board of directors and executive officers. For investors, this marks the final stage of the company's existence as an independent public entity, with shareholders receiving the agreed-upon cash and CVR consideration. The stock is currently trading near the cash portion of the offer price, reflecting the market's full absorption of the acquisition news.